Raman Spectroscopy Test Could Improve Lyme Disease Diagnostics
By LabMedica International staff writers Posted on 09 Jan 2023 |
Lyme disease, the fastest growing vector-borne illness in the U.S., is challenging to diagnose and can only be treated in the early stages of infection. Once the infection spreads to the nervous and muscular systems, it is both harder to detect and less susceptible to antibiotics. Now, scientists are focusing on improving Lyme disease treatment outcomes by developing a test that’s both more accurate and more efficient than the current test for the infection.
Scientists at Texas A&M University (College Station, TX, USA) are testing Raman spectroscopy, a technique used to detect vibrations at the molecular level, as a diagnostic tool for Lyme disease. The results of their second paper published on Raman spectroscopy as a diagnostic tool for Lyme disease demonstrate that blood samples from mice and humans infected with the Lyme pathogen were more accurately identified with the Raman spectroscopy test than with the two-tiered serology, the only diagnostic method currently approved to diagnose Lyme disease in humans in the U.S.
The increased accuracy of Raman spectroscopy testing could improve Lyme disease diagnostic practices for both humans and animals believed to have been in contact with the disease. For animals, the new test would require a smaller sample that could easily be taken in the field away from a veterinary clinic or hospital, thus improving mobile veterinary practices. For humans, Raman spectroscopy testing could significantly decrease the amount of time needed to complete testing, increase the accuracy of the diagnosis, lower the cost of diagnosing the disease, and improve overall health outcomes by definitively diagnosing the disease earlier.
The scientists are in the process of validating the test through additional studies, and if the test is validated, it could become an important tool for diagnosing Lyme disease worldwide, especially in more remote areas outside the U.S. where the disease is prevalent, by enabling testing outside of traditional medical and hospital settings. Their first paper published on Raman spectroscopy is the first proof-of-concept study to have explored Raman spectroscopy to diagnose mice infected with the Lyme pathogen. Their second paper included data on testing Raman spectroscopy on samples from mice infected with European Lyme pathogens. The scientists expect to publish more findings in about two years from the next phase of their research that entails testing human samples in a blind manner.
“We’re trying to develop a better test that would be simple, inexpensive and accurate. By accurate, I mean highly sensitive and highly specific at the same time,” said Dr. Artem Rogovskyy, an associate professor at the Texas A&M School of Veterinary Medicine & Biomedical Sciences, who is conducting the research along with Dr. Dmitry Kurouski, an assistant professor in the Texas A&M Department of Biochemistry & Biophysics and the Department of Biomedical Engineering.
Related Links:
Texas A&M University
Latest Molecular Diagnostics News
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset